Kinfo
Atara Biotherapeutics, Inc. logo

Atara Biotherapeutics, Inc.

ATRANASDAQHealthcare·US · USD
$8.67
-1.09 (-11.17%)
Prices as of July 13, 2026 · market closed

Price

Key statistics

Valuation
Market cap78.12M USD
Enterprise value89.67M USD
Trailing P/E3.82
Forward P/E7.69
PEG ratio-0.04
Price / sales3.80
Price / book-3.27
Profitability
Gross margin75.97%
Operating margin-652.91%
Profit margin-40.91%
Return on assets-3.83%
Return on equity-84.90%
Income (TTM)
Revenue23.14M USD
Gross profit16.22M USD
EBITDA38.63M USD
Net income-9.47M USD
Diluted EPS-$1.22
Rev. growth (YoY)-99.50%
Balance sheet
Total cash8.36M USD
Total debt10.09M USD
Debt / equity-0.27
Current ratio2.16
Book value / share-$4.38
Cash flow (TTM)
Operating cash flow-25.88M USD
Levered free cash flow-17.00M USD
Shares & price
Shares outstanding8.51M
Float4.66M
Held by institutions52.46%
Beta0.09
50-day MA$9.47
200-day MA$9.89
52-week high$19.15
52-week low$3.92
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-06-11-0.33-0.09+72.73%2026-03-16-0.10-0.35−250.00%2025-11-12-0.66-0.32+51.52%2025-10-212.102.24+6.67%2025-08-11-0.320.19+159.38%
About Atara Biotherapeutics, Inc.

Atara Biotherapeutics Inc. is a biopharmaceutical company focused on developing innovative cell therapies and immunotherapies for patients with serious diseases. The company specializes in creating therapeutic solutions that address critical unmet medical needs across oncology and other disease areas. Atara Biotherapeutics leverages advanced cellular and molecular approaches to design treatments that can potentially offer significant clinical benefits. The company operates in the competitive biopharmaceutical sector, where it collaborates with research institutions, clinical partners, and investors to advance its pipeline of therapeutic candidates through development and regulatory pathways. Founded and headquartered in the United States, Atara Biotherapeutics represents the biotechnology industry's commitment to translating scientific innovation into transformative medical treatments for patients worldwide.

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Anhco Nguyen Ph.D.
Employees
13
Headquarters
Thousand Oaks, CA, United States

Frequently asked questions about Atara Biotherapeutics, Inc.